EUVIMEDEUVIMED entdecken
Crossref

Sterilized protective immunity induced by DAM and DAM+ in mouse models for both VACV and MPXV

Zhengrong Gao, Tingting Zheng, Jiahao Wu, Haoyi Ding, Jia Lu, Jiahui Si, Yuze Xu, Hao Liu, Guocan Yu, Renyi Ma, Jianxun Qi, Yunfei Zhao und 6 weitere

Science Bulletin · 2025

DOI: 10.1016/j.scib.2025.05.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2025. Verfasst von Zhengrong Gao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen 518038, China; Beijing Life Science Academy, Beijing 102200, China. Hauptthemen laut MEDLINE: Vaccinia virus, Monkeypox virus, Mpox, Monkeypox, Viral Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Excellent Young Scientists Fund, Peking University, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of mpox calls for the development of safer and more accessible next-generation vaccines. Based on a structure-guided "two-in-one" immunogen design strategy, we have previously developed an innovative protein-based monkeypox virus (MPXV) vaccine, DAM (Double A35 and M1), which addresses the issues of imbalanced bioavailability associated with cocktail vaccines and elicits superior antiviral immunity with a safety profile. In this study, we iteratively designed two "four-in-one" chimeric immunogens, DAM+s, using four MPXV antigens, M1, A29, A35, and B6. Although DAM+s elicited broader immune responses against four antigens, no additional benefit in either in vitro neutralization or in vivo protection against poxviruses was detected compared to DAM. Notably, vaccination-related tissue damage was observed in the live virus vaccine group, whereas all protein-based vaccines showed better safety and protection against lethal vaccinia virus (VACV) challenge. Together, these further demonstrate that DAM, with a minimal protein subunit of two components, is a promising immunogen to be further clinically developed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccinia virusMonkeypox virusMpox, MonkeypoxViral VaccinesAnimalsMiceFemaleAntibodies, ViralAntigens, ViralMice, Inbred BALB CDisease Models, AnimalVaccinationAntibodies, Neutralizing

Stichwörter der Autor:innen

DAMMonkeypox virusMpoxMulti-antigen fusionProtein-based vaccine

Substanzen

Antibodies, ViralAntigens, ViralViral VaccinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen 518038, China; Beijing Life Science Academy, Beijing 102200, China.
  • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China; Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.
  • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801,…
  • Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.
  • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

Förderung

  • Excellent Young Scientists Fund
  • Peking University
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Institute of Biophysics, Chinese Academy of Sciences
  • Chinese Academy of Sciences
  • National Key Research and Development Program

Zitieren

APA

Gao, Z., Zheng, T., Wu, J., Ding, H., Lu, J., Si, J., Xu, Y., Liu, H., Yu, G., Ma, R., Qi, J., Zhao, Y., Ran, J., Wang, Q., Ma, X., Liu, Z., Wang, H., & Gao, G. F. (2025). Sterilized protective immunity induced by DAM and DAM+ in mouse models for both VACV and MPXV. Science Bulletin. https://doi.org/10.1016/j.scib.2025.05.013

Vancouver

Gao Z, Zheng T, Wu J, Ding H, Lu J, Si J, et al. Sterilized protective immunity induced by DAM and DAM+ in mouse models for both VACV and MPXV. Science Bulletin. 2025. doi:10.1016/j.scib.2025.05.013

BibTeX
@article{Gao2025,
  author = {Gao, Zhengrong and Zheng, Tingting and Wu, Jiahao and Ding, Haoyi and Lu, Jia and Si, Jiahui and Xu, Yuze and Liu, Hao and Yu, Guocan and Ma, Renyi and Qi, Jianxun and Zhao, Yunfei and Ran, Jiaqi and Wang, Qihui and Ma, Xiaopeng and Liu, Zhida and Wang, Han and Gao, George Fu},
  title = {Sterilized protective immunity induced by DAM and DAM+ in mouse models for both VACV and MPXV},
  journal = {Science Bulletin},
  year = {2025},
  doi = {10.1016/j.scib.2025.05.013}
}
Kostenlos starten →